TRENTON, N.J.--(BUSINESS WIRE)--Abraham Abuchowski, Ph.D., considered the father of PEGylation, the most widely used protein drug delivery system in the world which has helped save and improve thousands of lives, including many with “Bubble Boy Disease,” will be honored with the 2015 Dr. Sol J. Barer Award for Vision, Innovation and Leadership, at the Gateway Gala, BioNJ’s 22nd Annual Dinner Meeting, Networking Event and Innovation Celebration on Feb. 5 at the Hilton, East Brunswick, NJ. Dr. Barer will present the award.
“Dr. Abuchowski has had a long and lasting impact on biotechnology in New Jersey and beyond”
PEGylation defines the modification of a protein, peptide or non-peptide molecule by the linking of one or more polyethylene glycol (PEG) chains. Medicines developed with a PEGylation delivery system have several advantages, including a prolonged residence in body, a decreased degradation by metabolic enzymes and a reduction or elimination of protein immunogenicity. Thanks to these favorable properties, PEGylation plays an important role in drug delivery, enhancing the potentials of peptides and proteins as therapeutic agents.